Free cash flow recovered to $249.9M in 2026Q2 (36.1% margin) from a $310.3M deficit in 2024Q4, yet cumulative OCF/NI of 0.79 and approximately $820M of negative cumulative free cash flow over ten quarters indicate earnings quality remains weaker than reported profits suggest.
Cmb.Tech N.V. (CMBT) cash flow statement — 10-year operating, investing & financing cash flows
| Metric | TTM | Dec'25 | Dec'24 | Dec'23 | Dec'22 | Dec'21 | Dec'20 | Dec'19 | Dec'18 | Dec'17 | Dec'16 |
|---|
| Cash from Operations | 777.33M | 443.38M | 439.34M | 854.9M | 260.24M | -24.33M | 1.04B | 272.78M | 782.93K | 225M | 417.72M |
| Operating CF Margin % | - | 26.61% | 46.73% | 69.22% | 29.9% | -6.03% | 80.12% | 29.17% | 0.13% | 41.17% | 64.02% |
| Operating CF Growth % | 1006.44% | 0.92% | -48.61% | 228.51% | 1169.44% | -102.34% | 281.58% | 34740.91% | -99.65% | -46.14% | - |
| Net Income | 835.67M | 167.24M | 833.42M | 875.98M | 206.98M | -325.78M | 507.93M | 112.56M | -106.66M | 1.47M | 194.56M |
| Depreciation & Amortization | 335.02M | 387.97M | 166.03M | 225.67M | 226.68M | 331.76M | 343.19M | 338.68M | 262.3M | 244.72M | 217.17M |
| Stock-Based Compensation | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Deferred Taxes | 0 | 0 | -3.97M | 1.15M | 1.14M | -189.44K | 1.47M | -465.35K | 195.73K | 0 | -108.7K |
| Other Non-Cash Items | -107.34M | -119.38M | -593.75M | -355.99M | -90.32M | -10.41M | -5.53M | -12.09M | -44.04M | -44.76M | -30.5M |
| Working Capital Changes | 75.44M | 7.56M | 37.62M | 108.1M | -84.24M | -19.72M | 193.81M | -165.9M | -111.01M | 23.56M | 36.6M |
| Change in Receivables | 33.39M | 52.98M | 102.07M | 42.79M | -115.15M | -20.91M | 101.61M | -21.72M | -104.51M | 36.95M | 33.52M |
| Change in Inventory | -21.15M | -29.64M | 4.97M | 19.53M | 27.89M | 6.49M | 115.49M | -161.59M | 0 | 0 | 0 |
| Change in Payables | -4.06M | 36.1M | -14.23M | 17.7M | -1.34M | -1.17M | 4.82M | 6.49M | -7.93M | 1.24M | -6.5M |
| Cash from Investing | -265.25M | -1.82B | -651.01M | 887.88M | -161.76M | -339.7M | -125.69M | 43.88M | 184.15M | -42.84M | -95.94M |
| Capital Expenditures | -482.34M | -1.07B | -1.07B | -345.75M | -550.15M | -397.46M | -241.94M | -8.08M | -230.68M | -189.39M | -326.76M |
| CapEx % of Revenue | 21.4% | 64.42% | 114.15% | 27.99% | 63.21% | 98.46% | 18.62% | 0.86% | 39.68% | 34.65% | 50.08% |
| Acquisitions | 290.5M | -755.7M | 542.7M | 1.23B | 363.27M | 53.7M | 85.95M | 82.5M | 284.89M | 103.14M | 209.77M |
| Investments | - | - | - | - | - | - | - | - | - | - | - |
| Other Investing | -73.4M | 8.95M | 3.44M | 1.74M | -8.33M | 1.91M | 1.92M | 1.25M | 0 | 43.41M | 21.06M |
| Cash from Financing | -517.12M | 1.49B | -165.54M | -1.49B | -64.05M | 359.55M | -1.07B | -191.74M | -155.2M | -250.16M | -249.01M |
| Debt Issued (Net) | 337.71M | 2.03B | 1.12B | -825.32M | -14.49M | 435.65M | -527.42M | -104.3M | -131.65M | -203.17M | -36.39M |
| Equity Issued (Net) | 0 | 0 | -121.46M | 0 | 1.1M | 0 | -127.17M | -31.05M | -1.61M | 0 | -5.87M |
| Dividends Paid | -15.18M | -20.98M | -1.08B | -643.74M | -24.67M | -23.28M | -377.85M | -26.09M | -21.94M | -46.98M | -206.75M |
| Share Repurchases | 0 | 0 | -121.46M | 0 | 0 | 0 | -127.17M | -31.05M | -1.61M | 0 | -5.87M |
| Other Financing | -839.66M | -521.71M | -84.39M | -22.4M | -26M | -52.82M | -40.55M | -30.3M | 0 | 0 | 0 |
| Net Change in Cash | -4.01M | 107.68M | -390.16M | 248.58M | 27.98M | -9.03M | -135.48M | 123.82M | 29.48M | -63.04M | 75.03M |
| Free Cash Flow | 295.1M | -628.34M | -632.47M | 509.22M | -273.02M | -421.69M | 799.18M | 264.72M | -229.9M | 35.62M | 90.98M |
| FCF Margin % | 13.09% | -37.71% | -67.27% | 41.23% | -31.37% | -104.46% | 61.52% | 28.31% | -39.54% | 6.52% | 13.94% |
| FCF Growth % | 130.72% | 0.65% | -224.21% | 286.51% | 35.25% | -152.76% | 201.9% | 215.15% | -745.44% | -60.85% | - |
| FCF per Share | 1.02 | -2.74 | -3.23 | 2.52 | -1.35 | -2.09 | 3.80 | 1.23 | -1.20 | 0.23 | 0.57 |
| FCF Conversion (FCF/Net Income) | 0.35x | 2.76x | 0.50x | 1.00x | 1.28x | 0.07x | 2.20x | 2.42x | -0.01x | 152.82x | 2.15x |
| Interest Paid | 85.19M | 0 | 109.14M | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Taxes Paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Quick answers to the most common questions about buying CMBT stock.
Cmb.Tech N.V. (CMBT) generated $443.4M in net cash from operating activities in 2025. This reflects the cash generated directly from core business operations.
Cmb.Tech N.V. (CMBT) reported negative free cash flow of $628.3M in 2025, indicating capital requirements exceeded cash from operations.
Cmb.Tech N.V. (CMBT) spent $1.07B on capital expenditures in 2025. CapEx represents the cash invested in physical assets like property, plant, and equipment to maintain or grow the business.
In 2025, Cmb.Tech N.V. (CMBT) returned $21.0M to shareholders via cash dividends. This shows the company's commitment to returning capital to its equity investors.
Key Metrics
Top Statement Risk
Capex outpaces operating cash generation
Earnings Conversion Runs Below Reported Profit
Across ten quarters, CMBT reported $1.80B of cumulative net income but generated only $1.41B of cumulative operating cash flow, an aggregate OCF/NI ratio of 0.79, with the latest quarter (2026Q2) showing $249.9M of OCF against $357.9M of net income (0.70), per CMBT quarterly cash flow statements.
The shortfall appears to be structural rather than episodic: operating cash has repeatedly failed to match reported earnings, most visibly in 2024Q2 when $183.4M of net income coincided with only $41.2M of OCF, a 0.22 conversion ratio that suggests a large portion of that quarter's profit was non-cash, plausibly reflecting vessel sale gains or equity-method revaluations typical of asset-heavy shipowners. Conversely, the very high conversion readings in 2025Q3 (7.23) and 2025Q2 (5.62) should not be read as earnings quality strength — those quarters reported depressed net income of $19.9M and $7.8M, so the ratio was inflated by a small denominator rather than by outsized cash generation. The 2026Q2 gap of roughly $108M between net income and OCF warrants scrutiny of whether the earnings profile is being supported by non-operating items; if so, the current cash flow strength may overstate the durability of the profitability improvement.
Fleet Expansion Absorbed Operating Cash
CMBT deployed approximately $2.23B of cumulative capital expenditure over ten quarters, peaking at $413.9M in 2024Q4 — equal to 183.1% of that quarter's revenue — before capex fell to $0 in 2026Q2, according to CMBT's reported cash flow statements.
This capex intensity is far above what maintenance alone would require, and the pattern suggests a heavy newbuild and fleet-consolidation program rather than routine replacement spending; the accompanying jump in quarterly depreciation from roughly $40–50M in 2024 to over $110M in 2026 implies a materially larger asset base is now in service. The zero-capex reading in 2026Q2 appears to mark the completion of a delivery cycle rather than a structural shift to capital-light operations, given that the H2 Infra and H2 Industry segments would, if scaling as described, likely require renewed construction outlays. Investors should therefore treat the current 36.1% FCF margin as potentially transitory, since the same hydrogen buildout that management has signaled could quickly re-introduce capex drag and compress free cash flow.
Free Cash Flow Rebounds After Deep Deficit
Free cash flow swung from a deficit of $310.3M in 2024Q4 to a surplus of $249.9M in 2026Q2 — a reversal of roughly $560M — yet cumulative free cash flow across the ten-quarter window remained negative at approximately $820M, per CMBT's quarterly filings.
The turnaround appears to be driven by two forces: the tapering of the vessel delivery program, which released capex pressure, and a meaningful acceleration in operating cash generation from $36.5M in 2025Q1 to $249.9M in 2026Q2, alongside the 77.2% revenue expansion noted in the income statement analysis. However, the trajectory should be read cautiously because the FCF inflection coincided with a capex freeze, and the company has provided no forward guidance to anchor the durability of the current run-rate. Given the historical pattern of lumpy capital deployment in this sector, the recent FCF strength may reflect timing effects on the delivery calendar rather than a sustainable step-change in the fleet's cash economics.
Large Distributions Alongside Volatile M&A
CMBT paid out approximately $1.27B in dividends across the ten-quarter period, including $879.6M in 2024Q2 and $205.8M in 2024Q3, while simultaneously posting major acquisition cash flows of $1.1B in 2023Q4 and $1.0B in 2025Q1, based on reported cash flow statements.
The scale and irregularity of these distributions is notable: dividends collapsed to near zero through much of 2025 before re-emerging at $15.2M in 2025Q4, a pattern that suggests capital return decisions were being re-prioritized as the fleet buildout and hydrogen integration consumed cash. Because cumulative operating cash flow over the window ($1.41B) exceeded cumulative dividends ($1.27B) by only a narrow margin, the distributions appear to have been funded substantially from asset sales, financing, or divestiture proceeds rather than purely from recurring operations — a dynamic that may not repeat if cash generation softens. With buybacks remaining negligible (only $572.2M in total, concentrated in 2024), the deployment profile is heavily dividend-weighted, and investors should monitor whether the resumption of distributions is sustainable alongside a potential restart in capital expenditure.
Reported Earnings Outpace Cash Reality
Over ten quarters, cumulative net income of $1.80B exceeded cumulative operating cash flow of $1.41B by roughly $390M, and after $2.23B of capex and $1.27B of dividends, the company posted cumulative negative free cash flow of about $820M, per CMBT's quarterly financial statements.
The divergence is concentrated in the early part of the window — 2024Q1 reported $495.2M of net income and 2023Q4 reported $406.6M, yet both quarters produced weaker operating cash conversion (0.45 and 0.65 respectively), a pattern that is consistent with lumpy, potentially non-cash gains embedded in reported earnings, such as vessel sale gains, which are common in this industry and explicitly flagged as an accounting nuance in the company's reporting profile. The practical implication is that the headline earnings figures overstate the cash-generating capacity of the business during that period, and any valuation anchored to reported net income without adjusting for this gap may be overstated. The recent quarters show signs of convergence — 2026Q2 operating cash of $249.9M against $357.9M of net income — but the cumulative record suggests investors should treat reported profitability with a discount until a sustained period of OCF-at-or-above-net-income is demonstrated.
Cash Flow Statement May Understate Transition Cost
CMBT reported $0 in stock-based compensation and no capital expenditure in 2026Q2, despite an active hydrogen integration strategy, suggesting that costs of the strategic pivot may be routed through acquisition or capitalized lines rather than visible operating or capex outlays, based on reported cash flow statements.
The complete absence of SBC across ten quarters means there is no hidden dilution to adjust for, but it also removes a common signal of how a company compensates and retains technical talent — relevant given the hydrogen technology claims. More consequentially, the $1.0B and $1.1B acquisition cash outflows in 2025Q1 and 2023Q4, combined with zero reported R&D expense on the income statement, suggests that spending on the H2 segments may be being capitalized or structured through entities that are not fully consolidated into the operating cash line; if so, reported operating cash flow may not represent the full economic cost of the transition. Additionally, large positive working capital contributions totaling approximately $162M cumulatively — including $112.3M in 2023Q4 and $91.0M in 2024Q1 — may be temporarily flattering operating cash flow, and their reversal could pressure conversion ratios. Neither the funding source of the H2 buildout nor the accounting treatment of related development costs is transparently visible in the provided data, and this warrants further investigation into segment-level disclosures.